copia de analytical information 30 sep 2010
TRANSCRIPT
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
1/12
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
2008
(USD in thousands except earnings per share) Q1 Q2 Q3 Q4 TOTAL
Continuing operations:
Revenues 31,523 37,077 44,984 27,121 140,705
Cost of sales (26,822) (24,190) (33,586) (25,764) (110,362
Gross profit 4,701 12,887 11,398 1,357 30,343
Net adjustment from change in fair value of biological assets 1,644 (867) (1,050) 17,349 17,076
Profit after adjusment from biological assets 6,345 12,020 10,348 18,706 47,419
Administrative expenses (3,469) (3,380) (2,200) (3,610) (12,659
Selling expenses (3,391) (3,886) (4,944) (4,065) (16,286
Other income 273 1,144 28 (712) 733
Other expenses (538) (1,640) 373 (3,001) (4,806
Operating profit (780) 4,258 3,605 7,318 14,401
Share of gain (loss) of associated companies - 67 - (146) (79
Financial income 1,739 124 314 (202) 1,975
Financial costs (3,283) (2,051) (2,888) (3,152) (11,374Change in fair value of derivative financial instruments 5,810 (5,485) (7,211) 6,886 -
Currency translation differences 1,425 (1,270) (3,699) (498) (4,042
Profit (loss) before income tax 4,911 (4,357) (9,879) 10,206 881
Income tax (808) 649 1,654 (1,391) 104
Profit (loss) for the period from continuing operations 4,103 (3,708) (8,225) 8,815 985
Discontinued operations:
Loss for the period from discotinued operations - - - - -
Profit (loss) for the period 4,103 (3,708) (8,225) 8,815 985
Depreciation & Amortization 1,280 2,674 682 1,682 6,318
Workers Profit Sharing 727 (609) (1,226) 915 (193
Amortization without IAS-41 377 418 538 490 1,823Stock options - 239 256 66 561
EBITDA A.F.V.A. 1,492 7,058 2,916 13,694 25,160
EBITDA B.F.V.A. 225 8,343 4,504 (3,165) 9,907
Net profit (loss) attributable to:
Non-controlling interests - - - - -
Equity holders of Camposol Holding PLC 4,103 (3,708) (8,225) 8,815 985
Earnings per share in USD
From continuing operations:
Basic 0.147 (0.131) (0.287) 0.302 0.034
Diluted 0.147 (0.131) (0.287) 0.302 0.034
From discontinued operations:
Basic - - - - -
Diluted - - - - -
From total operations:
Basic 0.147 (0.131) (0.287) 0.302 0.034
Diluted 0.147 (0.131) (0.287) 0.302 0.034
Average outstanding shares in millions*)
For Basic calculation
Outstanding shares*) during the quarter. 27,925,070 28,212,690 28,693,799 29,174,909 29,174,909
Outstanding shares*) year to date. 27,925,070 29,833,820 29,833,820 29,833,820 29,833,820
For Diluted calculation
Outstanding shares*) during the quarter. 27,925,070 28,212,690 28,693,799 29,174,909 29,174,909
Outstanding shares*) year to date. 27,925,070 29,833,820 29,833,820 29,833,820 29,833,820*) Weighted average number of ordinary outstanding shares.
Number of ordinary shares at end of period 27,925,070 29,833,820 29,833,820 29,833,820 29,833,820
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
2/12
CAMPOSOL HOLDING PLC
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
2008
(USD in thousands) 31 Mar 30 Jun 30 Sep 31 Dec 31 Mar
Assets
Non-current assets
Property, plant and equipment, net 106,075 107,509 115,324 120,360 119,917
Investments in associated companies 417 421 420 274 274Intangibles 27,140 28,611 29,117 27,580 27,268
Non-current portion of biological assets 84,406 84,846 86,833 99,962 108,154
Other accounts receivable 5,012 - - - -
Total non-current assets 223,050 221,387 231,694 248,176 255,613
Current assets
Prepaid expenses 2,408 2,516 1,821 1,339 1,211
Current portion of biological assets 10,177 11,025 4,666 15,386 13,161
Inventories 41,609 52,423 64,269 58,037 46,473
Other accounts receivable 10,980 16,740 18,233 14,077 16,221
Trade accounts receivable 31,870 35,892 36,722 25,822 22,160
Cash and cash equivalents 24,176 27,262 21,094 5,770 5,215
Total current assets 121,220 145,858 146,805 120,431 104,441Total assets 344,270 367,245 378,499 368,607 360,054
Equity and liabilities
Capital and reserve attributable to
shareholders of the Company
Capital stock 25,895 507 507 507 507
Share premium 179,525 228,991 229,266 212,318 212,318
Share Warrants - - - 4,114 4,114
Share options - 239 495 745 745
Cash flow hedge - - - (11,093) (8,970)
Retained earnings 17,288 369 (7,099) 14,545 14,476
222,708 230,106 223,169 221,136 223,190
Minority interests 88 88 88 88 88
Total equity 222,796 230,194 223,257 221,224 223,278
Non-current liabilities
Long-term debt 65,388 69,675 66,853 56,826 52,553
Deferred income tax 17,423 13,112 10,933 10,094 10,467
Other payables 581 4,908 15,865 19,707 17,256
83,392 87,695 93,651 86,627 80,276
Current liabilities
Accounts payable to related companies 346 - - 8 -
Current portion of long-term debt 5,481 4,621 6,634 9,528 13,382
Trade payables 22,842 21,485 28,412 25,126 18,735
Other payables 9,411 8,372 11,795 9,638 8,449
Bank loans 2 14,878 14,750 16,456 15,93438,082 49,356 61,591 60,756 56,500
Total liabilities 121,474 137,051 155,242 147,383 136,776
Total equity and liabilities 344,270 367,245 378,499 368,607 360,054
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
3/12
2009 2010
30 Jun 30 Sep 31 Dec 31 Mar 30 Jun 30 Sep 31 Dec
118,775 116,583 111,927 110,329 108,896 115,526
574 266 422 601 600 38626,962 26,637 26,586 26,583 26,490 27,303
110,899 116,629 125,802 133,087 137,223 143,120
- - - - - -
257,210 260,115 264,737 270,600 273,209 286,335 -
825 579 643 819 544 543
8,462 7,817 15,031 10,324 9,216 10,420
37,022 34,103 32,033 31,583 27,977 29,333
17,430 14,410 12,445 12,409 15,120 12,493
24,818 19,295 20,589 14,809 14,201 12,803
1,191 2,255 5,696 5,322 10,545 13,236
89,748 78,459 86,437 75,266 77,603 78,828 -346,958 338,574 351,174 345,866 350,812 365,163 -
507 507 507 507 507 507
212,318 212,318 212,318 212,318 212,318 212,318
4,114 4,114 2,050 2,050 2,050 2,050
819 1,062 914 959 991 1,026
(3,854) (574) - - - -
10,646 11,253 18,628 16,704 11,396 19,265
224,550 228,680 234,417 232,538 227,262 235,166 -
88 88 88 88 88 516
224,638 228,768 234,505 232,626 227,350 235,682 -
48,355 44,105 48,319 43,890 60,449 62,224
10,044 10,349 13,414 13,256 14,053 13,786
11,455 8,432 10,140 10,144 10,740 10,640
69,854 62,886 71,873 67,290 85,242 86,650 -
94 - -
15,560 17,293 8,635 11,728 3,193 3,991
16,797 13,726 20,262 18,137 16,500 21,367
6,784 6,954 6,614 5,419 6,555 6,973
13,231 8,947 9,285 10,666 11,972 10,50052,466 46,920 44,796 45,950 38,220 42,831 -
122,320 109,806 116,669 113,240 123,462 129,481 -
346,958 338,574 351,174 345,866 350,812 365,163 -
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
4/12
CAMPOSOL HOLDING PLC
CONSOLIDATED STATEMENT OF CASH FLOWS
2008
(USD in thousands) 1Q 2Q 3Q 4Q
Cash flow from operating activities
Collections 43,022 31,739 45,470 38,021Payment to suppliers and employees (46,503) (33,425) (49,433) (44,947)
Interest paid (2,904) (2,386) (2,869) (3,133)
Other collections 10,190 (12,883) 6,315 5,152
Income tax paid (565) (255) (17) (1,292)
Net cash provided by (used in) operating activities 3,240 (17,210) (534) (6,199)
Cash flow from investing activities
Purchases of property, plant and equipment (13,035) (3,254) (10,776) (2,649)
Purchases of intangibles (208) (501) (605) (432)
Proceeds from sale of property, plant and equipment - - 140
Interest received on bank deposits - - 1,416
Payments of permanent plantations - 951 (951)Other assets 109 - (109)
Net cash (used in) provided by investing activities (13,243) (3,646) (10,430) (2,585)
Cash flow from financial activities
Bank loans and overdrafts (1,476) 14,876 (128) 1,706
Repayment of borrowings (63,267) (2,573) 65,840 (7,000)
Payment to Camposol AS shareholders - - (320)
Debt termination fee - - - -
Capital contribution, net of transaction cost 9,156 11,639 650 (442)
Capital reduction - (320) 320
Proceeds from related companies - (597) 597
Proceeds from long-term debt, net - (60,649) (1,401)
Net cash (used in) provided by financial activities (55,587) 23,942 4,796 (6,540)
Net (decrease) increase in cash and cash equivalents during the period (65,590) 3,086 (6,168) (15,324)
Cash and cash equivalents at beginning of period 89,766 24,176 27,262 21,094
Cash and cash equivalents at end of period 24,176 27,262 21,094 5,770
- - - -
Conciliation
Operating activities:
Profit before income tax 4,911 (4,357) (9,879) 10,206
More (less) adjustments to profit net:Depreciation 1,219 2,181 332 1,378
Amortization 277 277 351 303
Provision for doubtful accounts receivable - - 3,435
Provision for obsolescence of inventories - - -
Write down of inventories - - -
Biological assets (7,895) (1,289) 4,372 (12,264)
Adjustment of retain earnings 2,123 (2,123) - -
Fixed assets adjustement - 2,556 (2,556)
Adjustment of intangibles - - -
Goodwill adjustment - (1,666) 1,666
Income tax expense - (1,511) 508 1,003
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
5/12
Embedded derivative 379 (335) 19 (425)
Net cost of fixed assets sold - 552 426 (922)
Interest expenses - - (1,416)
Change in derivative financial instrument (6,746) 6,421 7,211 (5,275)
Investment recovery - (67) - 67
Income tax and workers' profit sharing 412 438 (2,179) 948
Stock options expense - 239 256 66
Loss of investments in associates - - 79
Write-off of accounts receivables - - (1,315)Translation adjustment - 136 1,796 (1,501)
Increase (decrease) on the operations flow for net variations
Account payables to related companies (251) (346) 597 -
Trade receivables 11,499 (5,338) 486 9,175
Other receivables 7,004 (12,671) 5,418 3,761
Inventories (4,327) (9,809) (14,145) (3,053)
Prepaid expenses (601) 96 677 1,015
Trade payables 5,329 (1,357) 6,927 (3,286)
Other payables (10,093) 11,653 (4,597) (7,288)
Net cash provided by (used in) operating activities 3,240 (17,210) (534) (6,199)
- - - -
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
6/12
2009 2010
TOTAL Q1 Q2 Q3 Q4 TOTAL 1Q 2Q 3Q 4Q
158,252 36,572 28,552 31,523 31,416 128,063 31,611 27,944 31,823(174,308) (34,515) (26,166) (25,801) (27,887) (114,369) (30,773) (28,191) (33,172)
(11,292) (2,770) (2,606) (2,465) (2,438) (10,279) (2,485) (1,999) (2,357)
8,774 1,660 2,116 5,759 3,804 13,339 2,253 4,039 4,286
(2,129) 496 (806) (193) (538) (1,041) (214) (201) (194)
(20,703) 1,443 1,090 8,823 4,357 15,713 392 1,592 386 -
(29,714) (1,049) (434) (1,054) (1,337) (3,874) (697) (712) (4,971)
(1,746) (29) (35) (18) (126) (208) (114) (176) (101)
140 16 77 111 4,282 4,486 - 5,147
1,416 5 1 3 (9) - - -
- - - - - - -- - - - - - -
(29,904) (1,057) (391) (958) 2,810 404 (811) (888) 75 -
14,978 (522) (2,703) (4,284) 718 (6,791) 1,381 1,306 (1,472)
(7,000) - - - - - -
(320) - - - - - -
- - - - - (3,682) -
21,003 - - - - - -
- - - - - - -
- - - - - - -
(62,050) (419) (2,020) (2,517) (4,444) (9,400) (1,336) 6,895 3,702
(33,389) (941) (4,723) (6,801) (3,726) (16,191) 45 4,519 2,230
(83,996) (555) (4,024) 1,064 3,441 (74) (374) 5,223 2,691
89,766 5,770 5,215 1,191 2,255 5,770 5,696 5,322 10,545
5,770 5,215 1,191 2,255 5,696 5,696 5,322 10,545 13,236
- - - - - - - - -
- -
881 (42) (4,980) 290 8,144 3,412 (2,078) (4,512) 7,601 -
5,110 1,511 1,506 1,495 1,656 6,168 1,569 1,602 1,563
1,208 341 341 343 177 1,202 117 273 194
3,435 - 86 2,542 2,628 - 170 (8)
- - - 2,500 2,500 126 315 410
- - - 1,493 1,493 - (628) (776)
(17,076) (5,968) 1,955 (5,086) (16,386) (25,485) (2,578) (3,028) (7,101)
- - - - - - -
- - - - - - -
- - - - - - 211
- - - - - - -
- - - - - - -
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
7/12
(362) 371 370 - (741) - - -
56 6 49 (195) 433 293 22 (955) (1,640)
(1,416) (5) (1) (3) 10,636 10,627 2,322 7,968 1,759
1,611 (308) (743) (477) (83) (1,611) - -
- - - - - - -
(381) 494 (2,774) (360) 6,282 3,642 (82) 1,321 (367)
561 74 243 (61) 256 45 32 35
79 (300) 308 (156) (148) (178) - 214
(1,315) - - - - - -431 (29) 9 (11) (50) (81) 83 (134) 80
- - - - - -
15,822 3,662 (2,658) 5,496 (3,838) 2,662 5,780 573 1,382
3,512 (2,144) (1,209) 4,068 865 1,580 36 732 (144)
(31,334) 11,564 9,451 2,919 (429) 23,505 323 3,919 (990)
1,187 (242) 15 246 677 696 (176) 275 -
7,613 (7,726) (1,938) (3,071) 7,863 (4,872) (2,124) (1,672) 4,901
(10,325) (42) 1,923 2,532 (17,167) (12,754) (2,815) (4,659) (6,938)
(20,703) 1,443 1,090 8,823 4,357 15,713 392 1,592 386
- - - - - - - - - -
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
8/12
TOTAL
91,378(92,136)
(6,841)
10,578
(609)
2,370
(6,380)
(391)
5,147
-
--
(1,624)
1,215
-
-
(3,682)
-
-
-
9,261
6,794
7,540
5,696
13,236
13,236
1,011
4,734
584
162
851
(1,404)
(12,707)
-
-
211
-
-
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
9/12
-
(2,573)
12,049
-
-
872
112
36
-29
-
7,735
624
3,252
99
1,105
(14,412)
2,370
-
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
10/12
CAMPOSOL HOLDING PLC
SEGMENT INFORMATION
2008
(USD in thousands) sparagusAvocado Artichoke Pepper Mango Shrimp Other
Revenues 62,073 31,611 16,963 13,255 8,621 5,367 2,815
Cost of goods sold (55,474) (11,111) (15,964) (12,724) (6,760) (4,596) (3,733)
Gross profit 6,599 20,500 999 531 1,861 771 (918)
Volumes produced (net MT) 21,893 19,784 3,585 7,450 8,641 536 -
Volumes sold (net MT) 17,877 19,734 4,771 6,890 8,783 748 -
Weighted Average prices (US$ /Kg.) 3.47 1.60 3.56 1.92 0.98 7.18 -
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
11/12
-
8/6/2019 Copia de Analytical Information 30 Sep 2010
12/12
As of 30 Sep 2010
Avocado Artichoke Pepper Mango Grapes Shrimp Other TOTAL
19,718 45 7,818 12,980 384 3,494 3,163 83,481
(7,493) (72) (5,278) (7,027) (193) (3,216) (4,129) (56,181)
12,225 (27) 2,540 5,953 191 278 (966) 27,300
12,032 - 1,931 9,461 85 467 - 34,635
12,050 16 3,078 9,910 210 479 - 37,662
1.64 2.81 2.54 1.31 1.83 7.29 -